Pfizer Receives FDA Approval For Geodon(R) (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults
Links shared publicly online about this topic.
- 1,581total visits
Pfizer Receives FDA Approval For Geodon(R) (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults
Pfizer announced that the u.s. food and drug administration (fda) has approved geodon® (ziprasidone hci) capsules for maintenance treatment of bipolar i disorder as an adjunct to lithium or va
View full resource at medicalnewstoday.com
Tags: Antipsychotic Medication, Disease and Condition, Drug, FDA, Geodon, Zeldox, Eskalith, Pfizer
Most Recently Shared on November 23, 2009 at 3:40 pm By:
Pfizer Receives FDA Approval For Geodon(R) (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment .. http://bit.ly/07JCNcs
Also Shared By:
Advertisement
MNT Mental Health
@mnt_mentalhealt
Pfizer Receives FDA Approval For Geodon(R) (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment .. http://bit.ly/07JCNcs
1 year ago...